UAE Oncology Therapeutics Market Analysis

UAE Oncology Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the UAE Oncology Therapeutics Market will reach a value of $1.8 Bn from $0.91 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030. The Oncology Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Medpharma, and Julphar. The Oncology Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for UAE Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.

ID: IN10AEPH042 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Dr. Vishwa Modhia

Buy Now

UAE Oncology Therapeutics Market Analysis Summary

By 2030, it is anticipated that the UAE Oncology Therapeutics Market will reach a value of $1.8 Bn from $0.91 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030.

United Arab Emirates (UAE) is a high-income, developing country located in the Middle East bordering the Gulf of Oman and the Persian Gulf. Cancer is the UAE's third biggest cause of death; cancer care in the UAE has expanded significantly over the preceding 40 years, from a single centre in Al Ain in 1981 to more than 30 cancer centres and clinics around the UAE today, including at least four comprehensive cancer facilities.

The total number of newly diagnosed cancer cases (malignant and non-malignant) reported to the UAE National Cancer Registry (UAENCR) in 2019 was 4633. Breast, thyroid, colorectal, skin, and leukaemia scored first among all new cancer cases in both sexes. The Emirates Oncology Society (EOS) is the official organisation in the UAE that represents oncology healthcare providers. UAE's government spent 5.5% of its GDP on healthcare in 2020.

UAE Oncology Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

Precision oncology, defined as tumour genetic profiling to identify targetable alterations, is rapidly advancing and has reached mainstream clinical practice in the United Arab Emirates. The United Arab Emirates is an excellent regional corporate trading hub. In the UAE, cancer therapies, including the most modern FDA-approved drugs, are widely available. The UAE approval process is short, and many medications are approved soon after they are approved by the FDA. The UAE is committed to reducing cancer mortality by roughly 18% by 2025. Reduced cancer mortality is one of the main performance metrics of the UAE's national agenda as a "Pillar of World-Class Healthcare." These aspects could boost UAE Oncology Therapeutics Market.

Market Restraints

Despite significant gains in medical care, cancer quality control remains inadequate across the UAE, with significant disparities in cancer care across cancer centres. Access to clinical trials is still hampered by a lack of expertise and research infrastructure, as well as a small population, which makes patient recruitment challenging. Instead of the current opportunistic screening technique, a UAE-wide national screening programme with a call-and-recall system covering breast, colorectal, cervical, lung, and prostate cancer is required. These factors may deter new entrants into the UAE Oncology Therapeutics Market.

Competitive Landscape

Key Players

  • Julphar: Julphar is a UAE-based pharmaceutical company that produces a range of cancer therapeutics, including chemotherapy drugs and targeted therapies. The company has a strong focus on research and development and has several innovative cancer drugs that are currently in clinical development
  • Neopharma: Neopharma is a UAE-based pharmaceutical company that produces a range of cancer therapeutics, including chemotherapy drugs, targeted therapies, and biologics. The company has a strong presence in the Middle East and has expanded its operations to other countries in the region
  • Pharma International Company (PIC): PIC is a UAE-based pharmaceutical company that produces a range of cancer therapeutics, including chemotherapy drugs, targeted therapies, and biosimilars. The company has a strong focus on research and development and has several innovative cancer drugs that are currently in clinical development
  • Medpharma: Medpharma is a UAE-based pharmaceutical company that produces a range of cancer therapeutics, including chemotherapy drugs and targeted therapies. The company has a strong presence in the UAE and other countries in the Middle East

Notable Recent Deals

January 2023: The worldwide corporation Hikma Pharmaceuticals and the global biopharmaceutical company Celltrion Healthcare Co. have struck a new exclusive licencing deal for the anti-cancer medicine Vegzelma (CT-P16, bevacizumab). Celltrion Healthcare will be in charge of the development, production, and supply of Vegzelma, while Hikma will be in charge of the medicine's sales throughout all of its Mena markets, increasing access to an essential oncology product.

February 2022: Pfizer has expanded its cooperation with the cancer patient organisations Friends of Cancer Patients (FOCP) and Emirates Oncology Society, both of which are based in the UAE, to honour World Cancer Day. The pharmaceutical corporation has renewed its commitment to improving oncology care, boosting early identification, and supporting cancer treatment in the United Arab Emirates.

Healthcare Policies and Reimbursement Scenarios

In the United Arab Emirates (UAE), the administrative body liable for the endorsement and guidelines of remedial items, including disease therapeutics, is the Ministry of Health and Prevention (MOHAP). The repayment of malignant growth therapeutics under the public medical care framework in the UAE is dependent upon the health care coverage framework, which expects occupants to have health care coverage inclusion. The healthcare coverage framework in the UAE is managed by the Dubai Health Authority (DHA) and the Health Authority - Abu Dhabi (HAAD).

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Therapeutics Segmentation

By Application (Revenue, USD Billion):

  • Blood Cancer
  • ?Colorectal Cancer
  • Gastrointestinal Cancer
  • Gynaecologic Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • ?Others

By Drugs (Revenue, USD Billion):

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Temodar
  • Others

By Therapy (Revenue, USD Billion):

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 03 April 2023
Updated by: Dr. Purav Gandhi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up